Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q430194> ?p ?o }
Showing triples 1 to 27 of
27
with 100 triples per page.
- Q430194 subject Q6809004.
- Q430194 subject Q8431759.
- Q430194 subject Q8760074.
- Q430194 abstract "Figitumumab (previously CP-751871) is a monoclonal antibody targeting the insulin-like growth factor-1 receptor that was investigated for the treatment of various types of cancer, for example adrenocortical carcinoma and non-small cell lung cancer (NSCLC).This drug was being developed by Pfizer, but they ceased development of the drug in January 2011 and has stopped its manufacture.".
- Q430194 atcPrefix "none".
- Q430194 casNumber "943453-46-1".
- Q430194 fdaUniiCode "VE267FC2UB".
- Q430194 wikiPageWikiLink Q12078.
- Q430194 wikiPageWikiLink Q128581.
- Q430194 wikiPageWikiLink Q14901457.
- Q430194 wikiPageWikiLink Q206921.
- Q430194 wikiPageWikiLink Q3658562.
- Q430194 wikiPageWikiLink Q422248.
- Q430194 wikiPageWikiLink Q6809004.
- Q430194 wikiPageWikiLink Q8431759.
- Q430194 wikiPageWikiLink Q8760074.
- Q430194 wikiPageWikiLink Q918285.
- Q430194 atcPrefix "none".
- Q430194 casNumber "943453".
- Q430194 unii "VE267FC2UB".
- Q430194 type ChemicalSubstance.
- Q430194 type Drug.
- Q430194 type ChemicalObject.
- Q430194 type Thing.
- Q430194 type Q8386.
- Q430194 comment "Figitumumab (previously CP-751871) is a monoclonal antibody targeting the insulin-like growth factor-1 receptor that was investigated for the treatment of various types of cancer, for example adrenocortical carcinoma and non-small cell lung cancer (NSCLC).This drug was being developed by Pfizer, but they ceased development of the drug in January 2011 and has stopped its manufacture.".
- Q430194 label "Figitumumab".